Tai Dora K C, Kim Hoon Yub, Park Dawon, Russell Jonathon O, Tufano Ralph P, Kandil Emad
Department of Surgery, Queen Elizabeth Hospital, Kowloon, Hong Kong, Jordan.
Department of Surgery, Korea University Thyroid Center, Korea University College of Medicine, Seongbuk-gu, Seoul, Republic of Korea.
Ann Surg Oncol. 2020 Oct;27(10):3842-3848. doi: 10.1245/s10434-020-08429-2. Epub 2020 Apr 6.
Transoral robotic thyroidectomy (TORT) for differentiated thyroid carcinoma is increasing in popularity. However, studies are limited to small tumors. This study aimed to compare the outcomes of TORT for papillary thyroid carcinomas smaller than 1 cm and 1 cm or larger.
The study analyzed 269 patients with papillary thyroid carcinoma who underwent TORT at Korea University Hospital, Korea between January 2001 and December 2017. Surgical outcomes and postoperative complications were compared.
Group 1 (tumor < 1 cm) had 215 patients, and group 2 (tumor ≥ 1 cm) had 54 patients. The majority of the patients underwent lobectomy (95.8% in group 1 and 87.0% in group 2; p = 0.339) and unilateral central neck dissection (96.3% in group 1 and 88.9% in group 2; p = 0.024). The two groups did not differ significantly in terms of gender, age, body mass index, thyroiditis status, Da Vinci model. or operative procedure. The majority of the tumors in group 1 (73%) had T1a staging, whereas the majority of the tumors in group 2 were stage T1b or T3a (44.4% in each group; p = 0.000). Most of the patients in group 1 had N0 staging (59.1%), whereas most of the patients in group 2 had N1a staging (55.6%; p = 0.026). The mean operative time was significantly longer in group 2 (198.0 ± 34.2 min in group 1 vs. 215.7 ± 49.3 min in group 2; p = 0.015). The two groups did not differ significantly regarding length of stay, postoperative pain score, or thyroglobulin level. No patients experienced locoregional or distant recurrence. No statistically significant difference in overall complications was observed (p = 0.214).
Transoral robotic thyroidectomy is a safe and effective procedure and may be a feasible option for patients with papillary thyroid carcinomas larger than 1 cm.
经口机器人甲状腺切除术(TORT)治疗分化型甲状腺癌的应用越来越广泛。然而,相关研究仅限于小肿瘤。本研究旨在比较TORT治疗直径小于1 cm和直径大于或等于1 cm的乳头状甲状腺癌的疗效。
本研究分析了2001年1月至2017年12月在韩国高丽大学医院接受TORT治疗的269例乳头状甲状腺癌患者。比较手术效果和术后并发症。
第1组(肿瘤<1 cm)有215例患者,第2组(肿瘤≥1 cm)有54例患者。大多数患者接受了甲状腺叶切除术(第1组为95.8%,第2组为87.0%;p = 0.339)和单侧中央区颈淋巴结清扫术(第1组为96.3%,第2组为88.9%;p = 0.024)。两组在性别、年龄、体重指数、甲状腺炎状态、达芬奇手术系统型号或手术方式方面无显著差异。第1组大多数肿瘤(73%)为T1a期,而第2组大多数肿瘤为T1b期或T3a期(每组44.4%;p = 0.000)。第1组大多数患者为N0期(59.1%),而第2组大多数患者为N1a期(55.6%;p = 0.026)。第2组的平均手术时间明显更长(第1组为198.0±34.2分钟,第2组为215.7±49.3分钟;p = 0.015)。两组在住院时间、术后疼痛评分或甲状腺球蛋白水平方面无显著差异。没有患者出现局部或远处复发。总体并发症方面未观察到统计学显著差异(p = 0.214)。
经口机器人甲状腺切除术是一种安全有效的手术方法,对于直径大于1 cm的乳头状甲状腺癌患者可能是一种可行的选择。